We concluded that the most common reason for the failure of our treatment before the year 2016 was insufficient laser therapy in APROP and in the zone I ROP; therefore, we changed the treatment strategy for anti-VEGF injection as a first-line treatment followed, in chosen cases, by supplementary laser therapy. Here, VEGFA is linked to retinopathy of prematurity.